Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV.

Front Immunol · 2023 · PMC10017959 · PMID 36936952

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant

As shown in Table S12 , the rate of infection with SARS-CoV-2 Omicron variant was slightly higher in non-seroconverters compared to seroconverters; however, this did not reach statistical significance (80.00% vs 83.33%, P > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.